Metadherin promotes podocyte injury and proteinuria through activating cAMP/PKA/β-catenin signaling

WCN23-0693
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine
 
 
 
 
Metadherin promotes podocyte injury and proteinuria through activating cAMP/PKA/β-catenin signaling
Chen, X.(1)*;Xiao, J.(1);Tao, D.(2);Liang, Y.(1);Chen, S.(1);Shen, L.(1);Li, S.(1);Zheng, Z.(1);Zeng, Y.(1);Luo, C.(1);Peng, F.(1);Long, H.(1);
ie: Azwin Z.1, Siti Y.1, John D.2
(1)Zhujiang Hospital- Southern Medical University, Department Of Nephrology, Guangzhou, China;(2)Zhujiang Hospital- Southern Medical University, Department Of Gerontology, Guangzhou, China;
https://storage.unitedwebnetwork.com/files/1041/39354e62c4abdcaad837006658e3d8a5.pdf
 
if any